SCHEMBL8285751

SCHEMBL8285751

CC1=NS(=O)(=O)c2ncncc21

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
DGAT1 O75907 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286627 0.69 CA12 (0.45) CYP1A2CYP3A4CYP2D6
SCHEMBL18818680 0.61 CDC25B (0.32) CDC25B
SCHEMBL475129 0.60
SCHEMBL8285766 0.59 KDM4E (0.31)
SCHEMBL8285762 0.59
SCHEMBL8286616 0.58 CA12 (0.45) CYP1A2CYP3A4CYP2D6
SCHEMBL19252986 0.57
SCHEMBL8623591 0.56
SCHEMBL26951480 0.56 CYP17A1 (0.40) CYP1A2CYP3A4CYP2D6DGAT1
SCHEMBL23235898 0.54 CDC25B (0.65) CDC25BCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed